InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Kirkpatrick Lynn, Chief Executive Officer. Director active across 1 company, notably Ensysce Biosciences, Inc.. Cumulatively, 3 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €32k. History available since 25 May 2022. The latest transaction was disclosed on 25 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
70,000 shares@ US$0.4869100.0% of flowCommon StockSEC:0001493152-22-015294:0
Ideal exit: 19 Feb 2023 (T+270)
284,851 sharesCommon StockSEC:0001192482-21-000618:0
284,851 sharesCommon StockSEC:0001192482-21-000618
3 of 3 declarations
About Kirkpatrick Lynn
Lynn Kirkpatrick is the CEO of Ensysce Biosciences, Inc. In this role, he is responsible for the overall management of the company and the implementation of its strategy. Ensysce Biosciences, Inc. is a biopharmaceutical company. Lynn leverages his expertise to lead the company towards sustainable growth and strengthen its market position.
